Literature DB >> 19803676

Early patterns of adherence in adolescents initiating highly active antiretroviral therapy predict long-term adherence, virologic, and immunologic control.

Jane C Lindsey, Ronald J Bosch, Bret J Rudy, Patricia M Flynn.   

Abstract

Mesh：

Year:  2009        PMID： 19803676      PMCID： PMC2832651          DOI： 10.1089/apc.2009.0081

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


× No keyword cloud information.
  9 in total

1.  HIV infection and AIDS in adolescents: an update of the position of the Society for Adolescent Medicine.

Authors:  Lawrence J D'Angelo; Cathryn Samples; Audrey Smith Rogers; Ligia Peralta; Lawrence Friedman
Journal:  J Adolesc Health       Date:  2006-01       Impact factor: 5.012

2.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.

Authors:  David R Bangsberg
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

3.  Long-term observation of adolescents initiating HAART therapy: three-year follow-up.

Authors:  Patricia M Flynn; Bret J Rudy; Jane C Lindsey; Steven D Douglas; Janet Lathey; Stephen A Spector; Jaime Martinez; Margarita Silio; Marvin Belzer; Lawrence Friedman; Lawrence D'Angelo; Elizabeth Smith; Janice Hodge; Michael D Hughes
Journal:  AIDS Res Hum Retroviruses       Date:  2007-10       Impact factor: 2.205

4.  Higher rates of viral suppression with nonnucleoside reverse transcriptase inhibitors compared to single protease inhibitors are not explained by better adherence.

Authors:  Sheri D Weiser; David Guzman; Elise D Riley; Richard Clark; David R Bangsberg
Journal:  HIV Clin Trials       Date:  2004 Sep-Oct

5.  Adherence to antiretroviral therapy among older children and adolescents with HIV: a qualitative study of psychosocial contexts.

Authors:  Cheryl Merzel; Nancy VanDevanter; Mary Irvine
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

6.  Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Authors:  Scott M Hammer; Joseph J Eron; Peter Reiss; Robert T Schooley; Melanie A Thompson; Sharon Walmsley; Pedro Cahn; Margaret A Fischl; Jose M Gatell; Martin S Hirsch; Donna M Jacobsen; Julio S G Montaner; Douglas D Richman; Patrick G Yeni; Paul A Volberding
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

7.  Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions.

Authors:  Bret J Rudy; Debra A Murphy; D Robert Harris; Larry Muenz; Jonathan Ellen
Journal:  AIDS Patient Care STDS       Date:  2009-03       Impact factor: 5.078

8.  The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

Authors:  Viviane D Lima; Richard Harrigan; David R Bangsberg; Robert S Hogg; Robert Gross; Benita Yip; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

9.  HIV/AIDS-specific quality of life and adherence to antiretroviral therapy over time.

Authors:  William C Holmes; Warren B Bilker; Hao Wang; Jennifer Chapman; Robert Gross
Journal:  J Acquir Immune Defic Syndr       Date:  2007-11-01       Impact factor: 3.731
  9 in total
  8 in total

1.  Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.

Authors:  Albert Y Liu; Nancy A Hessol; Eric Vittinghoff; K Rivet Amico; Elizabeth Kroboth; Jonathan Fuchs; Risha Irvin; R Craig Sineath; Travis Sanchez; Patrick S Sullivan; Susan P Buchbinder
Journal:  AIDS Patient Care STDS       Date:  2014-12       Impact factor: 5.078

2.  An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.

Authors:  Sybil G Hosek; Bret Rudy; Raphael Landovitz; Bill Kapogiannis; George Siberry; Brandy Rutledge; Nancy Liu; Jennifer Brothers; Kathleen Mulligan; Gregory Zimet; Michelle Lally; Kenneth H Mayer; Peter Anderson; Jennifer Kiser; James F Rooney; Craig M Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

3.  Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy.

Authors:  Vinie Kouamou; Justen Manasa; David Katzenstein; Alan M McGregor; Chiratidzo E Ndhlovu; Azure T Makadzange
Journal:  AIDS       Date:  2019-09-01       Impact factor: 4.177

4.  Group-based economic incentives to improve adherence to antiretroviral therapy among youth living with HIV: safety and preliminary efficacy from a pilot trial.

Authors:  Omar Galárraga; Anthony Enimil; Dennis Bosomtwe; Wangnan Cao; David H Barker
Journal:  Vulnerable Child Youth Stud       Date:  2019-12-27

5.  Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead.

Authors:  Aditya H Gaur; Marvin Belzer; Paula Britto; Patricia A Garvie; Chengcheng Hu; Bobbie Graham; Michael Neely; George McSherry; Stephen A Spector; Patricia M Flynn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09       Impact factor: 2.205

6.  Conditional Economic Incentives for HIV Treatment Adherence: Aligning Adolescent Developmental Hallmarks with Behavioral Economic Theory to Improve HIV Treatment Adherence.

Authors:  Teresa DeAtley; Abigail Harrison; Bulelwa Mtukushe; Brendan Maughan-Brown; Rudzani Muloiwa; Jackie Hoare; Omar Galárraga; Caroline Kuo
Journal:  AIDS Patient Care STDS       Date:  2022-07       Impact factor: 5.944

7.  The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.

Authors:  Sybil G Hosek; George Siberry; Margo Bell; Michelle Lally; Bill Kapogiannis; Keith Green; M Isabel Fernandez; Brandy Rutledge; Jaime Martinez; Robert Garofalo; Craig M Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

8.  Integrating Behavioral HIV Interventions into Biomedical Prevention Trials with Youth: Lessons from Chicago's Project PrEPare.

Authors:  Sybil G Hosek; Keith R Green; George Siberry; Michelle Lally; Christopher Balthazar; Pedro A Serrano; Bill Kapogiannis
Journal:  J HIV AIDS Soc Serv       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.